Indonesia Health

Aiming to bring its population of more than 250m under coverage by 2019, Indonesia continues to roll out its universal health care programme, or Jaminan Kesehatan Nasional (JKN). State-driven developments, as well as activity in the private sector, are triggering impressive growth across the health industry. According to estimates from consultancy Frost and Sullivan, the value of Indonesia’s health care market will reach $21bn in 2019, up from $7bn in 2014. However, government expenditure on health care remains relatively low at just 3.6% of GDP, one of the lowest rates in South-east Asia. In the years to come, greater investment will be vital as demand for services, facilities and equipment increases under JKN.

This chapter contains an interview with Fachmi Idris, President Director, BPJS Kesehatan.

Cover of The Report: Indonesia 2018

The Report

This chapter is from the Indonesia 2018 report. Explore other chapters from this report.

Interviews & Viewpoints

Sketch of Fachmi Idris, President Director, BPJS Kesehatan
Fachmi Idris, President Director, BPJS Kesehatan: Interview

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart